Karuna Therapeutics Inc. (KRTX) PT Raised to $167 at Wedbush, Following Earnings

November 4, 2021 2:40 PM EDT Send to a Friend
Wedbush analyst Laura Chico raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $167.00 (from $164.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login